inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a complex, immune-mediated, disorder which leads to several gastrointestinal and systemic manifestations determining a poor quality of life, disability, and other negative health outcomes. our knowledge of this condition has greatly improved over the last few decades, and a comprehensive management should take into account both biological (i.e., disease-related, patient-related) and non-biological (i.e., socioeconomic, cultural, environmental, behavioral) factors which contribute to the disease phenotype. from this point of view, the so called 4P medicine framework, including personalization, prediction, prevention, and participation could be useful for tailoring ad hoc interventions in IBD patients. In this review, we discuss the cutting-edge issues regarding personalization in special settings (i.e., pregnancy, oncology, infectious diseases), patient participation (i.e., how to communicate, disability, tackling stigma and resilience, quality of care), disease prediction (i.e., faecal markers, response to treatments), and prevention (i.e., dysplasia through endoscopy, infections through vaccinations, and post-surgical recurrence). finally, we provide an outlook discussing the unmet needs for implementing this conceptual framework in clinical practice.

Lenti, M.v., Scribano, M.l., Biancone, L., Ciccocioppo, R., Pugliese, D., Pastorelli, L., et al. (2023). Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease. FRONTIERS IN MEDICINE, 10 [10.3389/fmed.2023.1031998].

Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease

Biancone, Livia;Fantini, Massimo Claudio;Monteleone, Giovanni;
2023-01-01

Abstract

inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a complex, immune-mediated, disorder which leads to several gastrointestinal and systemic manifestations determining a poor quality of life, disability, and other negative health outcomes. our knowledge of this condition has greatly improved over the last few decades, and a comprehensive management should take into account both biological (i.e., disease-related, patient-related) and non-biological (i.e., socioeconomic, cultural, environmental, behavioral) factors which contribute to the disease phenotype. from this point of view, the so called 4P medicine framework, including personalization, prediction, prevention, and participation could be useful for tailoring ad hoc interventions in IBD patients. In this review, we discuss the cutting-edge issues regarding personalization in special settings (i.e., pregnancy, oncology, infectious diseases), patient participation (i.e., how to communicate, disability, tackling stigma and resilience, quality of care), disease prediction (i.e., faecal markers, response to treatments), and prevention (i.e., dysplasia through endoscopy, infections through vaccinations, and post-surgical recurrence). finally, we provide an outlook discussing the unmet needs for implementing this conceptual framework in clinical practice.
2023
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/12
Settore MEDS-10/A - Gastroenterologia
English
Crohn’s disease
clinical complexity
internal medicine
precision medicine
ulcerative colitis
Lenti, M.v., Scribano, M.l., Biancone, L., Ciccocioppo, R., Pugliese, D., Pastorelli, L., et al. (2023). Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease. FRONTIERS IN MEDICINE, 10 [10.3389/fmed.2023.1031998].
Lenti, Mv; Scribano, Ml; Biancone, L; Ciccocioppo, R; Pugliese, D; Pastorelli, L; Fiorino, G; Savarino, E; Caprioli, Fa; Ardizzone, S; Fantini, Mc; To...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
PERSONALIZE.pdf

accesso aperto

Descrizione: ARTICOLO
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.69 MB
Formato Adobe PDF
1.69 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/396604
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 3
social impact